Population pharmacokinetics of levofloxacin in Korean patients

J Chemother. 2016 Aug;28(4):308-13. doi: 10.1179/1973947815Y.0000000033.

Abstract

Levofloxacin (LVFX) has different effects depending on the area under the concentration-time curve (AUC)/minimum inhibitory concentration (MIC) ratio. While AUC can be expressed as dose/clearance (CL), we measured serial concentrations of LVFX in Koreans and tried to set a Korean-specific equation, estimating the CL of the antibiotic. In total, 38 patients, aged 18-87 years, received once daily intravenous LVFX doses of 500 mg or 250 mg, depending on their renal function. Four plasma samples were obtained according to a D optimal sampling design. The population pharmacokinetic (PK) parameters of LVFX were estimated using non-linear mixed-effect modeling (NONMEM, ver. 7.2). The CL of LVFX was dependent on creatinine clearance (CLCR) as a covariate. The mean population PK parameters of LVFX in Koreans were as follows: CL (l/hour) = 6.19 × (CLCR/75)(1.32). The CL of LVFX in Koreans is expected to be lower than that in Western people.

Keywords: Area under the concentration curve; Clearance; Levofloxacin; Population pharmacokinetics.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacokinetics*
  • Area Under Curve
  • Female
  • Humans
  • Levofloxacin / blood
  • Levofloxacin / pharmacokinetics*
  • Male
  • Middle Aged
  • Republic of Korea
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Levofloxacin